Literature DB >> 19099200

Subtelomeric analysis of pediatric astrocytoma: subchromosomal instability is a distinctive feature of pleomorphic xanthoastrocytoma.

Elena Grau1, J Balaguer, A Canete, F Martinez, C Orellana, S Oltra, M Hernandez, V Castel.   

Abstract

Astrocytic neoplasms are genetically heterogeneous; however a low frequency of genomic changes has been found in juvenile pilocytic astrocytoma (PA) in molecular studies. Concerning pleomorphic xanthoastrocytomas (PXA), recent studies have given heterogeneous results for chromosomal alterations. We studied the subtelomeric regions of 19 primary astrocytoma tumors. Results were near normality for the PA group with relative scarcity of chromosomal imbalances, except for the duplication of 3pter in 4/15 and deletion of 21qter in 5/15 of them. In contrast, a specific profile was observed in the 4 PXA tumoral samples. This involved 3pter, 14qter and 19pter duplication and 4qter, 6qter, 9qter, 13cen, 17pter, 18qter and 21qter deletion. Our results indicate that the chromosomal and genetic aberrations in PXAs differed from those typically associated with the diffusely infiltrating astrocytic and oligodendroglial gliomas. These genetic differences would likely contribute to the more favorable behavior of PXAs and may be helpful for molecular differential diagnosis of pediatric cerebral tumors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19099200     DOI: 10.1007/s11060-008-9763-6

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

1.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

2.  Imprinting of the Angelman syndrome gene, UBE3A, is restricted to brain.

Authors:  T H Vu; A R Hoffman
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

3.  Pediatric brain tumors: loss of heterozygosity at 17p and TP53 gene mutations.

Authors:  C Orellana; M Hernandez-Martí; F Martínez; V Castel; J M Millán; J A Alvarez-Garijo; F Prieto; L Badía
Journal:  Cancer Genet Cytogenet       Date:  1998-04-15

Review 4.  Cytogenetic analysis of 120 primary pediatric brain tumors and literature review.

Authors:  M B Bhattacharjee; D D Armstrong; H Vogel; L D Cooley
Journal:  Cancer Genet Cytogenet       Date:  1997-08

5.  Pleomorphic xanthoastrocytoma with 18-year survival. Case report.

Authors:  L Palma; A Maleci; N Di Lorenzo; G M Lauro
Journal:  J Neurosurg       Date:  1985-11       Impact factor: 5.115

6.  Cytogenetic analysis of 109 pediatric central nervous system tumors.

Authors:  E Neumann; D K Kalousek; M G Norman; P Steinbok; D D Cochrane; K Goddard
Journal:  Cancer Genet Cytogenet       Date:  1993-11

7.  Molecular genetic alterations in pleomorphic xanthoastrocytoma.

Authors:  W Paulus; D K Lisle; J C Tonn; H K Wolf; W Roggendorf; S A Reeves; D N Louis
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

8.  Comparative genomic hybridization analysis of astrocytomas: prognostic and diagnostic implications.

Authors:  Rodney N Wiltshire; James E Herndon; Annie Lloyd; Henry S Friedman; Darell D Bigner; Sandra H Bigner; Roger E McLendon
Journal:  J Mol Diagn       Date:  2004-08       Impact factor: 5.568

9.  CALL interrupted in a patient with non-specific mental retardation: gene dosage-dependent alteration of murine brain development and behavior.

Authors:  Suzanna G M Frints; Peter Marynen; Dieter Hartmann; Jean-Pierre Fryns; Jean Steyaert; Melitta Schachner; Bettina Rolf; Katleen Craessaerts; An Snellinx; Karen Hollanders; Rudi D'Hooge; Peter P De Deyn; Guy Froyen
Journal:  Hum Mol Genet       Date:  2003-07-01       Impact factor: 6.150

10.  Nonrandom chromosomal gains in pilocytic astrocytomas of childhood.

Authors:  F V White; D C Anthony; E J Yunis; N J Tarbell; R M Scott; D E Schofield
Journal:  Hum Pathol       Date:  1995-09       Impact factor: 3.466

View more
  7 in total

1.  Pleomorphic Xanthoastrocytoma: Natural History and Long-Term Follow-Up.

Authors:  Cristiane M Ida; Fausto J Rodriguez; Peter C Burger; Alissa A Caron; Sarah M Jenkins; Grant M Spears; Dawn L Aranguren; Daniel H Lachance; Caterina Giannini
Journal:  Brain Pathol       Date:  2014-12-05       Impact factor: 6.508

Review 2.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

Review 3.  Aggressive behavior and anaplasia in pleomorphic xanthoastrocytoma: a plea for a revision of the current WHO classification.

Authors:  Nesibe Kahramancetin; Tarik Tihan
Journal:  CNS Oncol       Date:  2013-11

Review 4.  Rare Primary Central Nervous System Tumors Encountered in Pediatrics.

Authors:  Kim Kramer
Journal:  J Child Neurol       Date:  2016-01-22       Impact factor: 1.987

5.  Genetic changes observed in a case of adult pilocytic astrocytoma revealed by array CGH analysis.

Authors:  Nives Pećina-Šlaus; Kristina Gotovac; Anja Kafka; Davor Tomas; Fran Borovečki
Journal:  Mol Cytogenet       Date:  2014-12-23       Impact factor: 2.009

6.  Pleomorphic Xanthoastrocytoma; Clinicopathological spectrum of An Intriguing neoplasm.

Authors:  Mariam Abid; Saroona Haroon; Aisha Hassan Memon; Zubair Ahmad; Sheema Habib Hasan
Journal:  Pak J Med Sci       Date:  2018 Mar-Apr       Impact factor: 1.088

7.  DNA methylation alterations in grade II- and anaplastic pleomorphic xanthoastrocytoma.

Authors:  Ramón Martínez; F Javier Carmona; Miguel Vizoso; Veit Rohde; Matthias Kirsch; Gabriele Schackert; Santiago Ropero; Werner Paulus; Alonso Barrantes; Antonio Gomez; Manel Esteller
Journal:  BMC Cancer       Date:  2014-03-20       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.